We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA PROPOSAL COULD WEAKEN MEDWATCH DATA, MERCK SAYS
FDA PROPOSAL COULD WEAKEN MEDWATCH DATA, MERCK SAYS
September 3, 2004
An FDA proposed rule requiring that the labeling of Rx drugs and some OTC drugs include a toll-free number for consumers to report adverse events could jeopardize the integrity of the MedWatch program, according to a major brand firm.